We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Biomarkers
Digital Poster
Clinical
Performance and Clinical Utility of Next Generation Sequencing in Head and Neck Cancer and Thyroid Cancer Pathways
Ian Sann Boon, United Kingdom
E25-10
Can pre-radiotherapy systemic immune-inflammation index predict prognosis in thymic epithelial tumors?
Alper Kahvecioglu, Turkey
E25-2498
Radical radiotherapy in malignant pleural mesothelioma induces changes in circulating T lymphocytes and soluble PD-L1 levels: a therapeutic option?
Alberto Revelant, Italy
E25-2855
The influence of radiotherapy on cellular senescence
Katarzyna Paal, Austria
E25-4496
Immunological inflammatory biomarkers can serve as prognostic predictors for liver mCRC patients undergoing SBRT treatment.
Kiril Zhelev, Bulgaria
E25-27
Circulating tumor DNA as a comprehensive recurrence risk biomarker after ablative radiotherapy for early-stage non-small cell lung cancer
Masaki Nakamura, Japan
E25-60
Analysis of the Relationship between Abnormal GPC5 Expression, Prognosis, and Immune Infiltration in Lung Adenocarcinoma
Xiaoming Yin, China
E25-66
Correlation between pre-treatment PSMA-PET and early PSA response in MR-guided SBRT with intraprostatic lesion boost for prostate cancer
Darren MC Poon, Hong Kong (SAR) China
E25-463
Dynamic changes in plasma proteins and metabolites: insights into nasopharyngeal carcinoma immunotherapy resistance
Xiaochuan Chen, China
E25-756
screening of clinical nutritional indicators influencing radiation enteritis associated with TNT in LARC
Chenying Ma, China
E25-1293
The role of proteomics in predicting the risk of radiation necrosis following SRS treatment for brain metastases
Paola Jablonska, Spain
E25-2305